# Hypertension, Antihypertensive Medication Use, and Risk of Psoriasis

> **NCT06075394** · — · COMPLETED · sponsor: **Xijing Hospital** · enrollment: 9294 (actual)

## Conditions studied

- Psoriasis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06075394
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2023-10-01
- **Target enrollment:** 9294 (ACTUAL)
- **Last updated:** 2023-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06075394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06075394, "Hypertension, Antihypertensive Medication Use, and Risk of Psoriasis". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06075394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
